The probability of Plasmodium vivax acute illness following primary infection and relapse in Papua New Guinea

Amanda Ross, Cristian Koepfli, Lincoln Timinao, Diggory Hardy, Tobias Thuering, Melanie Loeffel, Benson Kiniboro, Ingrid Felger and Ivo Mueller

PLOS Neglected Tropical Diseases, 2025, vol. 19, issue 10, 1-20

Abstract: Inoculation with Plasmodium vivax malaria parasites can lead to blood-stage infections from the primary infection and relapses from liver-stage parasites or non-circulating merozoites. Understanding the risk of clinical illness following primary infection and relapse would inform surveillance and intervention strategies, but the probabilities are uncertain in people living in endemic areas. A major difficulty lies in the inability to distinguish primary infections and relapses. In this study, we estimate the probabilities of clinical illness using the different seasonal patterns of primary infection and relapse. Children aged one to three years in Ilaita, Papua New Guinea, were followed up over 16 months for illness (fever with ≥500 parasites/µl) with fortnightly active and passive case detection, and for blood-stage infection every two months. Estimates of the number of primary infections and relapses for each two-month time-period, age-group, village and ITN use category were derived from previous analyses using genotyping data. In this study, we use a Bayesian statistical model to relate the number of observed P. vivax clinical cases in each covariate category to the expected numbers of primary infections and relapses. We include the cumulative number of primary infections experienced since birth as a proxy for acquired immunity. To reflect uncertainty, we use varying assumptions about whether relapses can cause illness in different circumstances. The probability of illness decayed exponentially with increasing cumulative numbers of primary infections experienced. The estimated probability of illness following relapses was lower than that for primary infection, how much lower depended on how they were defined. Later relapses within the same brood tended to have lower probabilities than earlier ones. Varying seasonally, relapses were estimated to contribute half of P. vivax illness in this cohort despite accounting for 80% of the force of blood-stage infection. The results can inform estimates of the burden of P. vivax and provide building blocks for mathematical models for predicting the impact of interventions. Interventions triggered by clinical cases would focus on more recent infections and age-groups with less acquired immunity.Author summary: The probability that a pathogen causes illness or is tolerated without symptoms is important for quantifying the burden of disease, designing surveillance and intervention strategies, and optimizing resource allocation. In the case of Plasmodium vivax, one of the malaria species to infect humans, blood-stage infections may be caused by the primary infection typically shortly after an infectious mosquito bite or by relapses weeks or months later from developmentally-arrested liver-stage parasites or potentially from non-circulating parasites in other organs.

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0013567 (text/html)
https://journals.plos.org/plosntds/article/file?id ... 13567&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pntd00:0013567

DOI: 10.1371/journal.pntd.0013567

Access Statistics for this article

More articles in PLOS Neglected Tropical Diseases from Public Library of Science
Bibliographic data for series maintained by plosntds ().